Author: Haixia Su; Sheng Yao; Wenfeng Zhao; Minjun Li; Jia Liu; Weijuan Shang; Hang Xie; Changqiang Ke; Meina Gao; Kunqian Yu; Hong Liu; Jingshan Shen; Wei Tang; Leike Zhang; Jianping Zuo; Hualiang Jiang; Fang Bai; Yan Wu; Yang Ye; Yechun Xu
Title: Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro Document date: 2020_4_14
ID: ixun0c8g_2
Snippet: (Qinghao), is a milestone in the treatment of malaria. TCMs as well as purified natural products also provide a rich resource for novel antiviral drug development. Several herbal medicines and natural products have shown antiviral activities against viral pathogens (8) (9) (10) (11) . Among these, the roots of Scutellaria baicalensis Georgi (Huangqin in Chinese) are frequently used in TCM for the prophylaxis and treatment of hepatitis and respira.....
Document: (Qinghao), is a milestone in the treatment of malaria. TCMs as well as purified natural products also provide a rich resource for novel antiviral drug development. Several herbal medicines and natural products have shown antiviral activities against viral pathogens (8) (9) (10) (11) . Among these, the roots of Scutellaria baicalensis Georgi (Huangqin in Chinese) are frequently used in TCM for the prophylaxis and treatment of hepatitis and respiratory disorders (12) (13) (14) . In the present study, an enzymatic assay was performed to test if the ingredients isolated from S. baicalensis are inhibitors of SARS-CoV-2 3CLpro. As a result, baicalin and baicalein, two bioactive components from S. baicalensis, are identified as novel inhibitors of SARS-CoV-2 3CLpro with an antiviral activity in the SARS-CoV-2 infected cells. A crystal structure of SARS-CoV-2 3CLpro in complex with baicalein, the first non-covalent, non-peptidomimetic small-molecule inhibitor, was also determined, revealing a unique binding mode of this natural product with the protease.
Search related documents:
Co phrase search for related documents- infected cell and natural product: 1
- present study and respiratory hepatitis: 1, 2
- present study and rich resource: 1
- present study and SARS infected cell: 1, 2, 3, 4, 5, 6, 7, 8
- present study and Scutellaria baicalensis: 1, 2, 3, 4
- present study and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- present study and small molecule inhibitor: 1, 2
- present study and test perform: 1, 2, 3, 4
- present study and treatment prophylaxis: 1, 2, 3, 4, 5, 6, 7
- present study and viral pathogen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- respiratory hepatitis and small molecule: 1, 2, 3
- respiratory hepatitis and treatment prophylaxis: 1, 2
- respiratory hepatitis and viral pathogen: 1, 2
- rich resource and SARS infected cell: 1
- rich resource and small molecule: 1
- SARS infected cell and small molecule: 1, 2
- small molecule and treatment prophylaxis: 1, 2, 3, 4, 5, 6, 7, 8
- small molecule and viral pathogen: 1, 2
- treatment prophylaxis and viral pathogen: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date